Interv Akut Kardiol. 2022;21(4):201-207 | DOI: 10.36290/kar.2022.028

Infective endocarditis in Complex Cardiovascular Center in Pilsen: patients' characteristics and microbial spectrum

Martin Brada, Richard Rokyta
Kardiologická klinika, Centrum vysoce specializované komplexní kardiovaskulární péče FN Plzeň,
Univerzita Karlova a LF Plzeň

Aim: To assess the set of patients with infective endocarditis (IE) in Complex Cardiovascular Center (CCC) in Pilsen and evaluate changes in microbial spectrum and prognosis of patients.

Methods: We used a retrospective analysis to identify 109 patients with the diagnosis of IE according to modified Duke criteria, who were hospitalised in CCC in Pilsen from May 2011 to April 2019. This eight-year time period was divided into two four-year intervals to compare the changes in the set of patients.

Results: The study included 85 men and 24 women. 56 patients (51 %) had native valve endocarditis (NVE), 35 patients (32 %) had prosthetic valve endocarditis (PVE) and 18 patients (17 %) had cardiac device related infective endocarditis (CDRIE). In the PVE group, 8 mechanical and 27 biological prosthesis (including 2 cases of IE after transcatheter aortic valve implantation - TAVI) were affected. When comparing the periods of May 2011 to April 2015 with May 2015 to April 2019, we found out a 14 % increase in the number of patients with IE. The number of patients with NVE decreased significantly (35 vs. 21, p = 0,001), while the number of patients with PVE (10 vs. 25, statistically significant, p = 0,0131) and CDRIE (6 vs. 12, statistically non-significant, p = 0,3017) increased. Staphylococcus aureus remains the dominant pathogen in NVE and CDRIE group (32 % and 33 %, respectively), while in PVE patients there were more often identified coagulase negative Staphylococci as a causative microbial agent (31 %). The overall in-hospital mortality rate was 23 %, relatively lower in patients with NVE (16 %), on the contrary, significantly higher in patients with PVE (31 %) a CDRIE (28 %).

Conclusion: This retrospective study confirms an increase of total incidence of infective endocarditis. The number of patients with NVE decreased significantly, while the number of patients with PVE and CDRIE increased. Patients with PVE and CDRIE also show higher mortality. The dominant pathogens are Staphylococcus aureus, coagulase negative Staphylococci and Enterococcus faecalis.

Keywords: infective endocarditis, epidemiology, microbial spectrum, mortality.

Received: August 9, 2022; Revised: September 29, 2022; Accepted: November 14, 2022; Published: December 19, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Brada M, Rokyta R. Infective endocarditis in Complex Cardiovascular Center in Pilsen: patients' characteristics and microbial spectrum. Interv Akut Kardiol. 2022;21(4):201-207. doi: 10.36290/kar.2022.028.
Download citation

References

  1. Marek D. Infekční endokarditida. In: Táborský M., Kautzner J., Linhart A. et al. Kardiologie, 1. vydání. Praha: Mladá fronta; 2017.
  2. Bínová J, Kubánek M, Koudelková E, et al. Vývoj spektra nemocných hospitalizovaných pro infekční endokarditidu v Kardiocentru IKEM v letech 2000-2013. Cor Vasa. 2016;58(6):e576-583. doi: 10.1016/j.crvasa.2015. 10. 008. Go to original source...
  3. Coufal P, Večeřa J, Matějka J, et al. Infekční endokarditida v kardiocentru bez kardiochirurgie: epidemiologické změny a prediktory mortality. Cor Vasa. 2019;61(4):e386-395. doi: 10.33678/cor.2019.036. Go to original source...
  4. Linhartová K. 2015 ESC Guidelines for the management of infective endocarditis. Summary document prepared by the Czech Society of Cardiology, Cor et Vasa. 2016;58:e107-e128. Go to original source...
  5. Matějovič M. Sepse a její nová definice. Postgraduální nefrologie. 2017;XV(1):4-8.
  6. Špinar J, Hradec J, Špinarová L, et al. Summary of the 2016 ESC Guidelines on the diagnosis and treatment of acute and chronic heart failure. Prepared by the Czech Society of Cardiology. Cor Vasa. 2016;58:e530-e568. Go to original source...
  7. Kautzner J, Doupal V, Neužil P. Doporučení ESC pro diagnostiku a léčbu synkopy, 2018. Souhrn dokumentu připravený Českou kardiologickou společností. Cor Vasa 2019;61:e158-e193. Go to original source...
  8. Miro Jose M, Ambrosioni J. Infective endocarditis: an ongoing global challenge. European Heart Journal. [Internet]. 2019;40(39):3233-3236. [cited 2022-03-12]. ISSN 0195-668X. Available from: doi:10.1093/eurheartj/ehz694. Go to original source... Go to PubMed...
  9. Habib G, Erba A P, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC­‑EORP EURO­‑ENDO (European infective endocarditis) registry: a prospective cohort study. European Heart Journal. [Internet]. 2019;40(39):3222-3232 [cited 2022-05-22]. ISSN 0195-668X. Available from: doi:10.1093/eurheartj/ehz620. Go to original source... Go to PubMed...
  10. Pazderník M. Current trends in infective endocarditis. Intervenční a akutní kardiologie. [Internet]. 2022;21(1): 27-34. [cited 2022-07-15]. ISSN 1213807X. Available from: doi:10.36290/kar.2022.004. Go to original source...
  11. Brink V D, Floris S, Swaans M J, et al. Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands. European Heart Journal - Quality of Care and Clinical Outcomes. [Internet]. 2017;3(2):141-147. [cited 2022-07-15]. ISSN 2058-5225. Available from: doi:10.1093/ehjqcco/qcw039. Go to original source... Go to PubMed...
  12. Richey R, Wray D, Stokes T; Guideline Development Group. Prophylaxis against infective endokarditis: summary of NICE guidance. BMJ. 2008;336(7647):770-771. Go to original source... Go to PubMed...
  13. Bor D H, Woolhandler S, Nardin R, et al. Infective Endocarditis in the U.S., 1998-2009: A Nationwide Study. PLoS ONE 8(3): e60033. doi:10.1371/journal.pone.0060033. Go to original source... Go to PubMed...
  14. Pazderník M, Holicka M, Pelouch, et al. Characteristics, management, and outcome of infective endocarditis in the Czech Republic: prospective data from the ESC EORP EURO­‑ENDO registry. Bratislava Medical Journal. [Internet]. 2021;122(02):95-100. [cited 2022-09-29]. ISSN 1336-0345. Available from: doi:10.4149/BLL_2021_014. Go to original source... Go to PubMed...
  15. Murdoch D R, Corey G R, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis­‑Prospective Cohort Study. Arch Intern Med. 2009;169:463-473. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.